These compounds may interact with:
Cathepsin L1
Potentially involved in: carcinoma; fascioliasis; gelatinous drop-like corneal dystrophy; atopic dermatitis; atypical teratoid / rhabdoid tumor; breast cancer; intraductal papillary-mucinous neoplasm (ipmn); lung adenocarcinoma; lung cancer; malignant mesothelioma; non-small cell lung cancer; osteosarcoma; pituitary cancer; psoriasis; spina bifida; ulcerative colitis; chronic hepatitis c
Disease data sourced from Pharos.